Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

By WebmasterMay 23, 2023November 1st, 2024No Comments

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

Previous PostVESTECK Continues to Help Patients Around the World
Next PostRelmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results